Related Experiment Video
Updated: Sep 11, 2025

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
Published on: January 10, 2015
How soon should alternative smoking cessation treatments be offered after incomplete response to nicotine replacement
Scott Veldhuizen1, Saron Yohannes2, Victor Tang3
1INTREPID Lab, Addictions Program, Centre for Addiction and Mental Health, 1025 Queen St. W., Toronto, ON M6J 1H4, Canada; Institute for Mental Health Policy Research and the Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Canada; Department of Family and Community Medicine, University of Toronto, 500 University Ave., Toronto, ON M5G 1V7, Canada.
Background:
Several effective interventions exist for tobacco dependence. These operate via different mechanisms, making treatment sequencing an important clinical option. As total time in treatment is often short, determining the length of each trial is crucial. In this analysis, we examine how cessation probability varies with time in treatment in a large program providing nicotine replacement therapy (NRT).
Methods:
We used data on 87,952 people enrolled in the Smoking Treatment for Ontario Patients (STOP) program between 2014 and 2024. We fit a log-logistic interval-censored survival model to examine cessation probability as a function of time in treatment. We adjusted for sociodemographic and clinical variables and included willingness to set a quit date as an ancillary parameter. We used multiple imputation to include cases with missing baseline variables.
Results:
The predicted probability of cessation was 15.5 % for the first week, 9.4 % for the second, and decreased to 3 % per week by 12 weeks. People who had set a quit date were markedly more likely to quit soon after initiation, but the general pattern of decreasing probability of full response was present for all participants.
Conclusion:
People receiving NRT are most likely to quit very early in their course of treatment, and become unlikely to do so after several weeks without full response. Given the limited length of most courses of care, this implies that an offer of alternative interventions, if available, might best be made after a relatively short trial of NRT.
More Related Videos
Related Concept Videos
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Antidepressant Drugs: MAOIs and Other Agents
Drug Dependence
CNS Depressants: Alcohol and Nicotine
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...

